In the latest trading session, 1.96 million Cns Pharmaceuticals Inc (NASDAQ:CNSP) shares changed hands as the company’s beta touched 1.12. With the company’s most recent per share price at $2.71 changing hands around $0.34 or 14.34% at last look, the market valuation stands at $4.06M. CNSP’s current price is a discount, trading about -43995.94% off its 52-week high of $1195.00. The share price had its 52-week low at $2.24, which suggests the last value was 17.34% up since then.

Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information

Instantly CNSP is in green as seen in intraday trades today. With action -35.32%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -54.99%, with the 5-day performance at -35.32% in the red. However, in the 30-day time frame, Cns Pharmaceuticals Inc (NASDAQ:CNSP) is -45.64% down.

The consensus price target for the stock as assigned by Wall Street analysts is 0.5, meaning bulls need a downside of -442.0% from its recent market value. According to analyst projections, CNSP’s forecast low is 0.5 with 0.5 as the target high. To hit the forecast high, the stock’s price needs a 81.55% surge from its current level, while the stock would need to tank 81.55% for it to hit the projected low.

Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders

Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund. With 6.87 shares estimated at $18903.0 under it, the former controlled 0.01% of total outstanding shares. On the other hand, Fidelity Series Total Market Index Fund held about 0.00% of the shares, roughly 759.0 shares worth around $2087.0.